Replies to post #2884 on Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Ha, the Zacks Equity Research jinx. Positive article from them and price is down at the moment. Still, I'd rather have positive one as opposed to the opposite

Zacks Equity Research
,Zacks•July 2, 2020
Spectrum Pharmaceuticals, Inc. SPPI was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.81 to $3.32 in the past one-month time frame.

The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Spectrum Pharma. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Spectrum Pharma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.